Pages that link to "Q38281298"

The following pages link to Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings (Q38281298):

Displaying 44 items.

• Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy (Q30234848) (← links)
• Options for improving effectiveness of rotavirus vaccines in developing countries. (Q30241442) (← links)
• Rice Bran and Probiotics Alter the Porcine Large Intestine and Serum Metabolomes for Protection against Human Rotavirus Diarrhea (Q33586440) (← links)
• Evaluating the Impact of Breastfeeding on Rotavirus Antigenemia and Disease Severity in Indian Children (Q35909569) (← links)
• Probiotics, antibiotics and the immune responses to vaccines. (Q35923837) (← links)
• Study of the Ability of Bifidobacteria of Human Origin to Prevent and Treat Rotavirus Infection Using Colonic Cell and Mouse Models (Q36160564) (← links)
• Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana (Q36179680) (← links)
• Diarrheal Diseases Hospitalization in Yemen before and after Rotavirus Vaccination (Q37089177) (← links)
• Norovirus vaccines: Correlates of protection, challenges and limitations (Q37135476) (← links)
• Anti-microbial peptide gene expression during oral vaccination: analysis of a randomized controlled trial (Q37319622) (← links)
• Relevance of secretor status genotype and microbiota composition in susceptibility to rotavirus and norovirus infections in humans (Q37728352) (← links)
• Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies (Q38599577) (← links)
• Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial (Q38797322) (← links)
• Molecular characterisation of wild-type G1P[8] and G3P[8] rotaviruses isolated in Vietnam 2008 during a vaccine trial (Q38974615) (← links)
• Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland. (Q39162563) (← links)
• Epidemiology of Rotavirus in the Iranian Children: A Systematic Review and Meta-analysis. (Q39353263) (← links)
• A Summary of the First HIV Microbiome Workshop 2015. (Q39706409) (← links)
• Group A Rotaviruses circulating prior to a National Immunization Programme in Nigeria: clinical manifestations, high G12P[8] frequency, intra-genotypic divergence of VP4 and VP7. (Q40041680) (← links)
• Human Milk Oligosaccharides: Potent Weapons in the Battle against Rotavirus Infection (Q40127552) (← links)
• Qualitative Effects of Monovalent Vaccination Against Rotavirus: A Comparison of North America and South America (Q40489579) (← links)
• A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis (Q40700056) (← links)
• Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors (Q46243057) (← links)
• An in-vitro transcription assay for development of Rotavirus VP7. (Q47144608) (← links)
• Causes of impaired oral vaccine efficacy in developing countries. (Q47794110) (← links)
• Evaluation of the Influence of Gastrointestinal Coinfections on Rotavirus Vaccine Effectiveness in Botswana (Q49492887) (← links)
• Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth (Q50303623) (← links)
• Monitoring shedding of five genotypes of RotaTeq vaccine viruses by genotype-specific real-time RT-PCR assays. (Q54094430) (← links)
• Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia. (Q54255267) (← links)
• Preventive Effect of a Synbiotic Combination of Galacto- and Fructooligosaccharides Mixture With Bifidobacterium breve M-16V in a Model of Multiple Rotavirus Infections. (Q55261664) (← links)
• Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines. (Q55423603) (← links)
• A Multiplex PCR/LDR Assay for Viral Agents of Diarrhea with the Capacity to Genotype Rotavirus (Q57940815) (← links)
• Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States (Q58546255) (← links)
• Composition of gut microbiota and its influence on the immunogenicity of oral rotavirus vaccines (Q59360996) (← links)
• Development of a live attenuated trivalent porcine rotavirus A vaccine against disease caused by recent strains most prevalent in South Korea (Q60920086) (← links)
• Rotavirus Double Infection Model to Study Preventive Dietary Interventions (Q61798228) (← links)
• Updates on immunologic correlates of vaccine-induced protection (Q91449694) (← links)
• Next-generation rotavirus vaccines: important progress but work still to be done (Q91597850) (← links)
• Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial (Q91597854) (← links)
• LAP+ Cells Modulate Protection Induced by Oral Vaccination with Rhesus Rotavirus in a Neonatal Mouse Model (Q91775785) (← links)
• Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age (Q92252858) (← links)
• Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries (Q92320554) (← links)
• The Impact of the Microbiome on Immunity to Vaccination in Humans (Q98460621) (← links)
• Impact of the intestinal environment on the immune responses to vaccination (Q99550506) (← links)
• A mixture model to assess the the immunogenicity of an oral rotavirus vaccine among healthy infants in Niger (Q101454717) (← links)